New Diagnostics clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Enable New Diagnostics for Pulmonary Microbes in People With CF
Sorry, not yet accepting patients
Sputum culture has been the best approach to detect harmful bacteria in the lungs of people with cystic fibrosis (CF). With the widespread use of new CF therapies (like Trikafta and Alyftrak), it is more difficult for people with CF to produce sputum even though they still have harmful bacteria in their lungs. The SEND-CF study is being done to see if there are other ways to detect harmful bacteria in the lungs.
at UCSD
Last updated: